MedTrace Logo

Antiperistaltic Effect and Safety of Glycopyrronium for Colonoscopic Polypectomy

NCT06041984 · Status: ENROLLING_BY_INVITATION · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-12-08

No results posted yet for this study

Summary

The purpose of this study is to determine the antiperistaltic effect and safety of glycopyrrolate and whether the use of glycopyrrolate is beneficial for colonoscopy and colonoscopic polypectomy.

Conditions

  • Glycopyrrolate
  • Colonoscopy

Interventions

DRUG

Glycopyrrolate

Intravenous injection of glycopyrrolate 0.2mg

OTHER

Placebo

Intravenous injection of saline 1ml

Sponsors & Collaborators

  • Jie Chen

    lead OTHER

Principal Investigators

  • Guangyou Duan, doctor · The Second Affiliated Hospital of Chongqing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-08
Primary Completion
2024-04-30
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06041984 on ClinicalTrials.gov